[PDF][PDF] Possible role for tocilizumab, an anti–interleukin-6 receptor antibody, in treating cancer cachexia

K Ando, F Takahashi, S Motojima… - Journal of Clinical …, 2013 - researchgate.net
Discussion The patient described in this report suffered from cancer cachexia, which is a
hypercatabolic state characterized by anorexia and weight loss associated with reductions in …

Development of slab tracks for Hokuriku Shinkansen line

K Ando, M Sunaga, H Aoki, O Haga - Quarterly Report of RTRI, 2001 - jstage.jst.go.jp
Thirty years have passed since the world's first use of slab tracks by the former Japanese
National Railways. It is recognized that they have excellent performance for maintaining good …

[HTML][HTML] Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer

K Ando, F Takahashi, M Kato, N Kaneko, T Doi, Y Ohe… - PloS one, 2014 - journals.plos.org
Background We previously reported the role of IL-6 in a murine model of cancer cachexia
and currently documented a patient in whom tocilizumab, anti-IL-6 receptor antibody, …

The efficacy and safety of low-dose sirolimus for treatment of lymphangioleiomyomatosis

K Ando, M Kurihara, H Kataoka, M Ueyama… - Respiratory …, 2013 - Elsevier
Background Lymphangioleiomyomatosis (LAM) is a rare disease caused by dysregulated
activation of the mammalian target of rapamycin (mTOR). Sirolimus, an inhibitor of mTOR, has …

Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis

T Nakashita, K Ando, N Kaneko, K Takahashi… - BMJ open, 2014 - bmjopen.bmj.com
Objectives Biological therapy represents important advances in alleviating rheumatoid arthritis
(RA), but the effect on interstitial lung disease (ILD) has been controversial. The objective …

Possible effect of abatacept on the progression of interstitial lung disease in rheumatoid arthritis patients

T Nakashita, K Ando, K Takahashi, S Motojima - Respiratory investigation, 2016 - Elsevier
Rheumatoid arthritis (RA) is a generally progressive, systemic autoimmune condition
characterized by chronic erosive synovitis. Interstitial lung disease (ILD) is a common extra-…

[HTML][HTML] Lung transplantation for lymphangioleiomyomatosis in Japan

K Ando, Y Okada, M Akiba, T Kondo, T Kawamura… - PLoS …, 2016 - journals.plos.org
Background Lung transplantation has been established as the definitive treatment option for
patients with advanced lymphangioleiomyomatosis (LAM). However, the prognosis after …

Effect of glucocorticoid monotherapy on pulmonary function and survival in Japanese patients with scleroderma-related interstitial lung disease

K Ando, S Motojima, T Doi, T Nagaoka, N Kaneko… - Respiratory …, 2013 - Elsevier
Background Scleroderma-related interstitial lung disease (SSc-ILD) is a chronic, progressive
condition that is characterized by a restrictive ventilator defect. Cyclophosphamide (CYC), …

The effect of comorbidity on the prognosis of acute lung injury and acute respiratory distress syndrome

K Ando, T Doi, SY Moody, Y Ohkuni, S Sato… - Internal …, 2012 - jstage.jst.go.jp
Objective We conducted a retrospective study assessing the relationship between comorbidity,
using the Charlson Comorbidity Index (CCI), and the prognoses of acute lung injury (ALI) …

Relationship between quantitative CT metrics and pulmonary function in combined pulmonary fibrosis and emphysema

K Ando, M Sekiya, K Tobino, K Takahashi - Lung, 2013 - Springer
Purpose Combined pulmonary fibrosis and emphysema (CPFE) is increasingly recognized,
as current reports of its clinical features show. To determine CPFE’s physiologic and …